Equity Economics worked with Katalis to produce this market insight which digs deep into the nuances of Indonesia’s booming fintech industry and how it can forge a connection with its neighbour Australia.

Equity Economics, in partnership with the National Aboriginal Community Controlled Health Organisation (NACCHO), undertook an analysis of the gap in health expenditure for Aboriginal and Torres Strait Islander people. In order to calculate the gap, we accounted for the burden of disease, which is more than twice the rate for the Aboriginal and Torres Strait Islander population than for the non-Indigenous population.

Australia’s first nationally coordinated effort to address rare diseases—the National Strategic Action Plan for Rare Diseases —called for the development of a national rare disease workforce strategy that responds to current and future demands, including the impact of genomics. This White Paper is an initial step to progress that priority.

Seven years ago, Equity Economics prepared a report for the McKell Institute’s: Funding Rare Disease Therapies in Australia – Ensuring equitable access to health for all Australians. The report placed the issue of inequities in access to new medicines for the one in eight Australians that live with a rare disease on the national policy agenda.

Equity Economics has undertaken an evaluation assessing the effectiveness and efficiency of activities undertaken by the National Aboriginal Community Controlled Health Organisation (NACCHO) under the Enhanced Syphilis Response (ESR).

Equity Economics has delivered a report in collaboration with the Health Services Union on meeting the challenge to improve residential aged care in Australia.

Equity Economics worked with The McKell Institute to deliver a report that explores the role complimentary medicines could play in achieving greater equity in the Australian healthcare system.